SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 2, 2003

Robbins & Myers, Inc.
Exact name of Registrant as specified in its charter)

Ohio	0-288	31-0424220
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)

1400 Kettering Tower, Dayton, OH	45423
(Address of principal executive offices)	(Zip code)

937-222-2610
(Registrant’s telephone number including area code)

Not applicable
(Former name and former address, if changed since last report)

Item 5. Other Events and Regulation FD Disclosure

In the Robbins & Myers, Inc. Annual Report on Form 10-K for the fiscal year ended August 31, 2002, there were certain non-GAAP financial measures presented. Following is a numerical reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measure:

	2002		2001		2000		1999		1998		1997
Net Income	$	14,503	$	19,631	$	18,056	$	11,849	$	31,230	$	28,866
Plus depreciation		20,028		16,161		16,293		16,861		15,846		10,793
Plus amortization		2,015		8,187		8,077		7,660		7,670		5,170
Plus interest		17,565		12,312		13,531		13,752		12,821		6,437
Plus minority interest		1,048		1,064		1,472		1,040		0		0
Plus income taxes		7,831		10,229		10,513		6,647		16,091		14,218
EBITDA	$	62,990	$	67,584	$	67,942	$	57,809	$	83,658	$	65,484

Reconciliation of Free Cash Flow to Net Cash and Cash Equivalents Provided by Operating Activities (Cash Flow from Operations) per consolidated statement of cash flows:

	2002		2001		2000		1999		1998		1997
Cash Flow from Operations	$	44,540	$	30,984	$	36,040	$	39,463	$	48,574	$	35,246
Less Capital expenditures, net of nominal disposals		15,112		20,200		19,842		11,612		23,020		22,071
Free Cash Flow	$	29,428	$	10,784	$	16,198	$	27,851	$	25,554	$	13,175

Reconciliation of Adjusted EBITA to Net Income per consolidated income statement:

	2002		2001		2000
Net income	$	14,503	$	19,631		$	18,056
Plus interest		17,565		12,312			13,531
Plus minority interest		1,048		1,064			1,472
Plus income taxes		7,831		10,229			10,513
Plus amortization		2,015		8,187			8,077
Plus non-recurring charges related to Global Reorganization		0		2,492			0
Plus Fairfield plant closure costs		0		0			409
Less gain on sale of Fairfield building		0		0			(918	)
Plus UGE long term receivable write-down		0		0			500
Adjusted EBITA	$	42,962	$	53,915		$	51,640

Reconciliation of Adjusted EBITA to Income before interest and Income Taxes by operating segment:

	Pharma-
Fiscal 2002	cuetical		Industrial		Energy
Income before interest and income taxes	$	27,895	$	5,279	$	18,773
Plus amortization		432		452		331
Adjusted EBITA	$	28,327	$	5,731	$	19,104

	Pharma-
Fiscal 2001	cuetical		Industrial		Energy
Income before interest and income taxes	$	17,349	$	8,445	$	26,078
Plus amortization		1,962		3,294		2,150
Plus non-recurring charges related to Global Reorganization		244		2,148		0
Adjusted EBITA	$	19,555	$	13,887	$	28,228

	Pharma-
Fiscal 2000	cuetical		Industrial		Energy
Income before interest and income taxes	$	24,448	$	12,007	$	16,130
Plus amortization		1,928		3,280		2,105
Plus Fairfield plant closure costs		0		0		409
Less gain on sale of Fairfield building		0		0		(918	)
Plus UGE long term receivable write-down		500		0		0
Adjusted EBITA	$	26,876	$	15,287	$	17,726

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Robbins & Myers, Inc.
Date: July 2, 2003	By:/s/ Kevin J. Brown Kevin J. Brown Vice President and Chief Financial Officer